Regulating Human Embryonic Stem Cell in China

"The general scope of the book is the patentability and morality of human embryonic stem cell research in US, EU and China. The book observes fraudsters operate unsafe human embryonic stem cell therapies and officialdom turns a blind eye to the immoral human embryonic stem cell research in China. The book highlights that both patent control and federal funding control are inefficient and ineffective way to monitoring human embryonic stem cell research. The book finally proposed an approach for china to regulating human embryonic stem cell research-regulating research itself at the reconciled international regime."--

שנה

2016

שפה

English

הוצאה

Springer

מהדורות

3

עמודים

200

ISBN

9789811021008

מקור הנתונים: Wikidata